Yanting Zou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yanting Zou has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fuhua Yan
Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, China
1 shared publication - Haichang Jiang
Department of Periodontology Nanjing Stomatological Hospital Affiliated Hospital of Medical School Institute of Stomatology Nanjing University Nanjing China
1 shared publication - Haiyang Pan
SEU‐FEI Nano‐Pico Center Key Lab of MEMS of Ministry of Education School of Integrated Circuits Southeast University Nanjing China
1 shared publication - Hua Hong
Department of Integrated Circuits, Southeast University, Nanjing 211189, China
1 shared publication - Litao Sun
SEU‐FEI Nano‐Pico Center Key Laboratory of MEMS of Ministry of Education Southeast University Nanjing P. R. China
1 shared publication - Mengjia Wang
Department of Periodontology Nanjing Stomatological Hospital Affiliated Hospital of Medical School Institute of Stomatology Nanjing University Nanjing China
1 shared publication
Latest Publications
- 13 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (34)
3D‐Printable and Bioelectronic‐Compatible Graphene‐Reinforced PLA Nanocomposites Rejuvenate Aged Bone Regeneration Through Glycolytic Reprogramming
Age‐related metabolic dysregulation, chronic inflammation, and impaired vascularization severely compromise critical‐sized bone healing. Building upon G‐PLA nanocomposites previously established for bioelectronic encapsulation, we herein investigate their potential as a bio‐instructive interface for guided bone regeneration. Fabricated via in situ graphite exfoliation, G‐PLA provides enhanced hydrophilicity, mechanical robustness, and bioactivity while preserving excellent 3D‐printability. In rat cranial defects, G‐PLA significantly accelerated regeneration, as demonstrated by micro‐CT, histological, and immunohistochemical analyses. Comparative evaluations in young and aged animals revealed that G‐PLA effectively mitigates age‐dependent declines in reparative capacity. Proteomic profiling indicated that G‐PLA orchestrates a pro‐regenerative microenvironment by inducing glycolytic reprogramming to meet the elevated energy demands of regeneration. In aged defects, G‐PLA upregulated glycolytic enzymes (e.g., ALDOA and HK2), enhanced angiogenesis (CD31/CD34), and suppressed inflammation‐ and senescence‐associated markers (e.g., P21 and SIRT2). In vitro studies validated that G‐PLA augments glycolytic flux in endothelial cells, enhances osteogenic differentiation of mesenchymal stem cells, and promotes macrophage polarization toward an anti‐inflammatory M2 phenotype. Therefore, G‐PLA nanocomposites transcend passive structural support to act as a bio‐instructive interface that revitalizes the aging‐associated vascular‐bone coupling, offering a versatile framework for next‐generation multifunctional implantable hybrid systems.
- 13 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (34)
3D‐Printable and Bioelectronic‐Compatible Graphene‐Reinforced PLA Nanocomposites Rejuvenate Aged Bone Regeneration Through Glycolytic Reprogramming
Age‐related metabolic dysregulation, chronic inflammation, and impaired vascularization severely compromise critical‐sized bone healing. Building upon G‐PLA nanocomposites previously established for bioelectronic encapsulation, we herein investigate their potential as a bio‐instructive interface for guided bone regeneration. Fabricated via in situ graphite exfoliation, G‐PLA provides enhanced hydrophilicity, mechanical robustness, and bioactivity while preserving excellent 3D‐printability. In rat cranial defects, G‐PLA significantly accelerated regeneration, as demonstrated by micro‐CT, histological, and immunohistochemical analyses. Comparative evaluations in young and aged animals revealed that G‐PLA effectively mitigates age‐dependent declines in reparative capacity. Proteomic profiling indicated that G‐PLA orchestrates a pro‐regenerative microenvironment by inducing glycolytic reprogramming to meet the elevated energy demands of regeneration. In aged defects, G‐PLA upregulated glycolytic enzymes (e.g., ALDOA and HK2), enhanced angiogenesis (CD31/CD34), and suppressed inflammation‐ and senescence‐associated markers (e.g., P21 and SIRT2). In vitro studies validated that G‐PLA augments glycolytic flux in endothelial cells, enhances osteogenic differentiation of mesenchymal stem cells, and promotes macrophage polarization toward an anti‐inflammatory M2 phenotype. Therefore, G‐PLA nanocomposites transcend passive structural support to act as a bio‐instructive interface that revitalizes the aging‐associated vascular‐bone coupling, offering a versatile framework for next‐generation multifunctional implantable hybrid systems.